Published in Cancer on November 15, 1989
Treatment of metastatic melanoma: an overview. Oncology (Williston Park) (2009) 4.58
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1). Cancer (2010) 1.22
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma. Mayo Clin Proc (2014) 1.06
Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res (2010) 1.01
Pathogenesis, diagnosis and management of primary melanoma of the colon. World J Surg Oncol (2011) 0.98
Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment. Front Oncol (2011) 0.94
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer (2009) 0.93
The history and future of chemotherapy for melanoma. Hematol Oncol Clin North Am (2009) 0.92
Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens. Cell Death Dis (2012) 0.90
Cutaneous Melanoma in Asians. Chonnam Med J (2016) 0.86
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes. Br J Cancer (2001) 0.84
Nodular melanoma presenting with rapid progression and widespread metastases: a case report. J Med Case Rep (2009) 0.82
Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV. Contemp Oncol (Pozn) (2013) 0.82
Chemotherapy in the management of advanced cutaneous malignant melanoma. Clin Dermatol (2013) 0.79
Systemic therapy of non-resectable metastatic melanoma. Cancers (Basel) (2010) 0.78
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study. Br J Cancer (1997) 0.77
The evolution in melanoma treatment as a reflection of precision-oriented medicine. Oncol Lett (2012) 0.76
Adult ileocolic intussusception presenting as small bowel metastatic melanoma. Radiol Case Rep (2015) 0.75
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
A public database for gene expression in human cancers. Cancer Res (1999) 8.81
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol (2001) 4.97
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A (2007) 4.27
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Conversion of diploidy to haploidy. Nature (2000) 3.28
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03
Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature (1997) 2.93
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat Genet (1998) 2.49
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis (2009) 2.04
Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron (1999) 2.00
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97
A new human genetic resource: a DNA bank established as part of the Avon longitudinal study of pregnancy and childhood (ALSPAC). Eur J Hum Genet (2000) 1.92
Induction of classical transplantation tolerance in the adult. J Exp Med (1989) 1.91
Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med (1990) 1.85
Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A (1999) 1.84
Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res (1994) 1.82
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
Starch branching enzymes belonging to distinct enzyme families are differentially expressed during pea embryo development. Plant J (1995) 1.68
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res (1995) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res (1994) 1.64
Low molecular weight RNA species from chromatin. Biochemistry (1975) 1.62
A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med (1986) 1.53
Genomic organization of the human PMS2 gene family. Genomics (1995) 1.50
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. Leukemia (2007) 1.47
Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol (2001) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Prognostic significance of HLA-DR antigen in dysplasia, carcinoma in situ and invasive carcinoma of the gallbladder. East Afr Med J (2003) 1.40
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol (1998) 1.32
CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol (1987) 1.31
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res (1995) 1.30
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. Ann Oncol (2013) 1.30
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg (1995) 1.24
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Segmental tuberculosis of the colon (a report of ten cases). Clin Radiol (1971) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology (1995) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Benign methylmalonic aciduria. N Engl J Med (1984) 1.22
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Branchial cysts. A report of 4 cases. Acta Dermatovenerol Alp Pannonica Adriat (2006) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18
Deafness from furosemide. Ann Intern Med (1970) 1.18
Abnormalities of urinary tract and skeleton associated with congenital absence of vagina. Br Med J (1966) 1.16
Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer (1989) 1.15
APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology (1994) 1.14
Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study. J Clin Microbiol (1989) 1.14
Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. J Affect Disord (1991) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Retracted NCL-CD30 staining of epithelial cells in the basal germinative layer of the epidermis and epithelial buds during foetal skin development. Clin Exp Med (2005) 1.09
Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol (1987) 1.09
ATR mediates cisplatin resistance in a p53 genotype-specific manner. Oncogene (2011) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2011) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther (1994) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
The ossified hyoid apparatus--morphology, interpretation, clinical and functional significance. Presentation of a rare case and highlights of the literature. Anat Anz (1988) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Accretion of low-metallicity gas by the Milky Way. Nature (1999) 1.06
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy (2006) 1.05
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience. Cancer J Sci Am (1997) 1.05
Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signaling cascade. J Neurosci (1997) 1.04
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha. Ann Oncol (1996) 1.03